RNA nasal spray: A groundbreaking innovation in treating memory loss and anxiety, offering new hope for more effective and non-invasive therapies.
Vous n'êtes pas connecté
Multiple sclerosis has a potential treatment under clinical trials - An antiallergy drug and green mamba snake toxin lead the way to discovery of new drug.
RNA nasal spray: A groundbreaking innovation in treating memory loss and anxiety, offering new hope for more effective and non-invasive therapies.
Discover how ICMR's new agreements for Phase 1 clinical trials mark a milestone in India's pharmaceutical research, targeting diseases like multiple...
KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...
A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...
A team of researchers in Japan has discovered a potential new way to treat Alzheimer’s disease using dopamine, a chemical naturally produced in the...
The Drugs Controller General of India (DCGI) has recently taken a significant decision under which the Central Drugs Standard Control Organisation...
South San Francisco, CA -- September 13, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United...
Xanadu Mines has launched into field programs at its Sant Tolgoi project in Mongolia, where it says it has uncovered multiple copper-nickel targets...
The Wuhan Institute of Virology has developed a new nasal Covid-19 vaccine intended to offer extensive protection against existing and future...